(Sharecast News) - Shares in Alliance Pharma slipped on Friday after the healthcare company said that its full-year results would be delayed.
Alliance, which had been due to publish its preliminary results for 2023 on 9 April, said figures are now expected to be released on 23 April.
"The group's auditor has determined that the volume of work required to complete the audit has exceeded its original expectations, necessitating a short delay in the reporting timetable," the statement said.
Nevertheless, the company assured that details provided in its latest trading update in January "remain accurate".
Alliance has already reported revenues of £182.7m for 2023, up 6% on the previous year, while underlying profits were said to be in line with market expectations.
The stock was down 2% at 37.66p by 0803 BST.
Alliance Pharma (APH)